A phase II study of cellular adoptive immunotherapy with donor-derived CMV-specific T-cell clones as prophylaxis for CMV disease in allogeneic HCT recipients

被引：0
|
作者：
Boeckh, M. [1 ]
Manley, T. [1 ]
Greenberg, P. [1 ]
Kirby, K. [1 ]
Riddell, S. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [41] Generation of CMV-specific T cells for adoptive immunotherapy after allogeneic BMT: A novel in vitro culture assay that is free of live virus which uses donor dendritic cells pulsed with CMV antigen.
    Verfuerth, S
    Peggs, K
    Mackinnon, S
    BLOOD, 1999, 94 (10) : 155A - 155A
  • [42] The Impact of Pre- and Week 4 Post-Transplant CMV-Specific Elispot Assay on CMV Reactivation and Survival in CMV-Seropositive Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients
    Ariza-Heredia, Ella J.
    Shah, Dimpy P.
    Winston, Drew J.
    Rowley, Scott D.
    Mullane, Kathleen M.
    Chandrasekar, Pranatharthi
    Hari, Parameswaran
    Avery, Robin K.
    Peggs, Karl S.
    Kumar, Deepali
    Nath, Rajneesh
    Ljungman, Per T.
    Mossad, Sherif B.
    Dadwal, Sanjeet S.
    Cruikshank, William
    Chemaly, Roy F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S47 - S48
  • [43] Cytomegalovirus-specific adoptive cellular therapy results in massive and persistent expansions of CMV-specific T-cells and significantly reduces the incidence of CMV reactivation following allogeneic transplantation.
    Peggs, K
    Verfuerth, S
    Pizzey, A
    Khan, N
    Moss, P
    Mackinnon, S
    BLOOD, 2001, 98 (11) : 779A - 779A
  • [44] ADOPTIVE T-CELL IMMUNOTHERAPY FOR TREATMENT OF GANCICLOVIR-RESISTANT CMV DISEASE AFTER LUNG TRANSPLANTATION
    Holmes-Liew, C.
    Holmes, M.
    Beagley, L.
    Hopkins, P.
    Chambers, D.
    Smith, C.
    Khanna, R.
    RESPIROLOGY, 2015, 20 : 117 - 117
  • [45] Cytomegalovirus (CMV)-Specific Polyfunctional T-Cell Responses after Letermovir (LET) Prophylaxis in Hematopoietic Cell Transplantation (HCT)
    Zamora, Danniel
    Akoto, Brenda
    Xie, Hu
    Kiener, Richard
    Edmison, Bradley C.
    Stevens-Ayers, Terry
    Wagner, Ralf
    Mielcarek, Marco
    Leisenring, Wendy M.
    De Rosa, Stephen
    Boeckh, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S68 - S69
  • [46] Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study
    Martin-Gandul, Cecilia
    Perez-Romero, Pilar
    Mena-Romo, Damian
    Molina-Ortega, Alejandro
    Gonzalez-Roncero, Francisco M.
    Suner, Marta
    Bernal, Gabriel
    Cordero, Elisa
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
  • [47] GENERATION OF CLINICAL-GRADE CMV-SPECIFIC T-CELLS: T-CELL DONOR SELECTION AND MANUFACTURING OF T CELLS
    Tischer, S.
    Priesner, C.
    Arseniev, L.
    Aleksandrova, K.
    Goudeva, L.
    Heuft, H. -G.
    Maecker-Kolhoff, B.
    Blasczyk, R.
    Koehl, U.
    Eiz-Vesper, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S331 - S332
  • [48] Isolation of donor derived CMV specific T-cells for the treatment of CMV disease in patients after in-vitro T-cell-depleted allogeneic stem cell transplantation
    Jedema, I
    Cox, LMP
    Meij, P
    Barge, RMY
    Willemze, R
    Falkenburg, JHF
    BONE MARROW TRANSPLANTATION, 2005, 35 : S26 - S26
  • [49] GENERATION OF CLINICAL-GRADE CMV-SPECIFIC T-CELLS: T-CELL DONOR SELECTION AND MANUFACTURING OF T CELLS
    Tischer, Sabine
    Priesner, Christoph
    Arseniev, Lubomir
    Goudeva, Lilia
    Aleksandrova, Krasimira
    Heuft, Hans-Gert
    Figueiredo, Constanca
    Maecker-Kolhoff, Britta
    Blasczyk, Rainer
    Koehl, Ulrike
    Eiz-Vesper, Britta
    TISSUE ANTIGENS, 2014, 84 (01): : 45 - 46
  • [50] Generation and administration of CMV pp65-specific donor T-cell lines for treatment of CMV reactivation after allogeneic stem cell transplantation
    Meij, P.
    Zandvliet, M. L.
    van der Heiden, P. L. J.
    Jedema, I.
    Egmond, E. M.
    Cox, L. M. P.
    de Meent, M. van
    Bongaerts, R.
    Hoogstraten, C.
    Guchelaar, H. J.
    Willemze, R.
    Falkenburg, J. H. F.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S28 - S29
12345